Trial Profile
Efficacy of Liraglutide and its impact on metabolic risk factors in patients with obesity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 07 Jul 2017 New trial record
- 20 May 2017 Results presented at the 24th European Congress on Obesity